PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
08-Feb-2021 PharmiWeb.Jobs Welcomes Biophorum PharmiWeb.Jobs
05-Feb-2021 The Lancet Publishes Two Phase 3 Studies Detailing Bimekizumab Data in Moderate to Severe Plaque Psoriasis UCB
05-Feb-2021 Achilles Therapeutics Announces Independent Data and Safety Monitoring Committee Review with a Positive Recommendation to Continue with Current Study Design of the Phase I/IIa CHIRON and THETIS Trials Achilles Therapeutics
03-Feb-2021 Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid Arthritis Imcyse
03-Feb-2021 Imcyse Announces Start of Phase 1b/2a IMPACT Study in Patients with Recent Onset Type 1 Diabetes Imcyse
03-Feb-2021 Three Key Start-ups Join SMi’s 2nd Annual AI in Drug Discovery Virtual Conference  SMi Group
02-Feb-2021 NEW HOPE FOR WOMEN WITH SUSPECTED ENDOMETRIAL CANCER AS INNOVATIVE URINE TEST RULES OUT DISEASE IN UP TO 99% OF CASES Arquer Diagnostics
02-Feb-2021 Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD Verona Pharma
02-Feb-2021 Bristol Myers Squibb Announces Positive Topline Results from Second Pivotal Phase 3 Psoriasis Study Showing Superiority of Deucravacitinib Compared to Placebo and Otezla® (apremilast) Bristol Myers Squibb
29-Jan-2021 Panthera continues to sign up new clinical trials across its UK network of dedicated clinical trial sites Panthera
29-Jan-2021 Epilepsy Therapeutic Market Therapeutic Development and Comprehensive Insights by 2026 Ameliorate Digital Consultancy PVT. LTD.
28-Jan-2021 Cancer Diagnostics Market Reviews and and Survey Report Forecast to 2025 (Based on COVID-19 North America Spread in 2020) Ameliorate Digital Consultancy PVT. LTD.
26-Jan-2021 Synairgen announces inclusion of its inhaled interferon beta treatment in US NIH ACTIV-2 trial in COVID-19 outpatients Synairgen
26-Jan-2021 First Patient Treated in Phase II Combination Trial of ISA Pharmaceuticals’ Lead Immunotherapy ISA101b with Keytruda® ISA Pharmaceuticals B.V.
26-Jan-2021 Panthera continues to sign up new clinical trials across its UK network of dedicated clinical trial sites Panthera
22-Jan-2021 PharmiWeb.Jobs Welcomes PRA Australia PRA Australia
22-Jan-2021 PharmiWeb.Jobs Welcomes Bausch & Lomb Bausch Health Companies Inc.
22-Jan-2021 Six key Microbiology presentations from FDA, STERIS, Boehringer Ingelheim Microbiological Consulting, Parexel SMi Group
21-Jan-2021 Sprint #4 Workshop: Bridging the silos between Clinical Research, eHealth & Digital Therapeutics - “The rise of patient-centric applications” Innovation Sprint
21-Jan-2021 Calliditas Announces Full Enrollment of the Phase 3 NefIgArd Trial Calliditas Therapeutics AB